Fatty acid synthase as a novel target for meningioma therapy
Open Access
- 5 February 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 12 (8), 844-854
- https://doi.org/10.1093/neuonc/noq004
Abstract
High levels of fatty acid synthase (FAS) expression have been reported in hormone receptor-positive tumors, including prostate, breast, and ovarian cancers, and its inhibition reduces tumor growth in vitro and in vivo. Similar to other hormone receptor-positive tumor types, meningiomas are progesterone receptor- and estrogen receptor-immunoreactive brain tumors. To define the role of FAS in human meningioma growth control, we first analyzed the FAS expression using a tissue microarray containing 38 meningiomas and showed increased FAS expression in 70% of atypical WHO grade II and anaplastic WHO grade III meningiomas compared with 10% of benign WHO grade I tumors. We next confirmed this finding by real-time PCR and Western blotting. Second, we demonstrated that treatment with the FAS inhibitor, cerulenin (Cer), significantly decreased meningioma cell survival in vitro. Third, we showed that Cer treatment reduced FAS expression by modulating Akt phosphorylation (activation). Fourth, we demonstrated that Cer treatment of mice bearing meningioma xenografts resulted in significantly reduced tumor volumes associated with increased meningioma cell death. Collectively, our data suggest that the increased FAS expression in human meningiomas represents a novel therapeutic target for the treatment of unresectable or malignant meningioma.Keywords
This publication has 40 references indexed in Scilit:
- Specific Genes Expressed in Association with Progesterone Receptors in MeningiomaCancer Research, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Fatty acid synthase: a novel target for antiglioma therapyBritish Journal of Cancer, 2006
- Meningioma Transcript Profiles Reveal Deregulated Notch Signaling PathwayCancer Research, 2005
- High‐level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt/PKBThe Journal of Pathology, 2005
- Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cellsOncogene, 2005
- Functional significance of S6K overexpression in meningioma progressionAnnals of Neurology, 2004
- Ceramide Disables 3-Phosphoinositide Binding to the Pleckstrin Homology Domain of Protein Kinase B (PKB)/Akt by a PKCζ-Dependent MechanismMolecular and Cellular Biology, 2003
- Alterations of the Tumor Suppressor Genes CDKN2A (p16INK4a), p14ARF, CDKN2B (p15INK4b), and CDKN2C (p18INK4c) in Atypical and Anaplastic MeningiomasThe American Journal of Pathology, 2001
- Expression of Fatty Acid Synthase Is Closely Linked to Proliferation and Stromal Decidualization in Cycling EndometriumInternational Journal of Gynecological Pathology, 1997